🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10100+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10100 recruiting trials

EARLY_Phase 1RecruitingNCT07240896

A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)

🏥 DSciLab Co., Ltd.📍 1 site📅 Started Dec 2025View details ↗
RecruitingNCT07330245

Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.

🏥 AstraZeneca📍 19 sites📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07289763

Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy

🏥 Guangdong Hengrui Pharmaceutical Co., Ltd📍 1 site📅 Started Dec 2025View details ↗
NARecruitingNCT07360808

Safety and Efficacy of Adipose-Derived Regenerative Cells (ADRCs) for Improving Hand Dysfunction in Systemic Sclerosis

🏥 Cytori Therapeutics📍 2 sites📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07276386

Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal Melanoma

👨‍⚕️ Jonathan Zager, MD, FACS, Moffitt Cancer Center📍 1 site📅 Started Dec 2025View details ↗
RecruitingNCT07229235

REAL-CARE: Real-world Effectiveness of Iptacopan in Italian Patients With Paroxysmal Nocturnal Hemoglobinuria

👨‍⚕️ Novartis Pharmaceuticals, Novartis Pharmaceuticals📅 Started Dec 2025View details ↗
RecruitingNCT07313943

PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE

🏥 IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 2 sites📅 Started Dec 2025View details ↗
Enrolling by InvitationNCT07391488

The Effects of Lumbopelvic Rhythm on Postural Control, Daily Activities, and Quality of Life in Individuals With AIS

🏥 Hacettepe University📍 1 site📅 Started Dec 2025View details ↗
NARecruitingNCT07231471

Platelet Rich Plasma for Musculoskeletal Conditions

🏥 University of Utah📍 1 site📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07294144

Tofersen in Non-SOD1 ALS

🏥 Washington University School of Medicine📍 1 site📅 Started Dec 2025View details ↗
EARLY_Phase 1RecruitingNCT07376642

A Phase I/IIa, Open-label, Single-center, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of IMV101 as a Single Agent in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

🏥 Suzhou Immunofoco Biotechnology Co., Ltd📍 4 sites📅 Started Dec 2025View details ↗
RecruitingNCT07390240

The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia

🏥 AstraZeneca📍 2 sites📅 Started Dec 2025View details ↗
Phase 3RecruitingNCT06994442

Optimizing Pain Treatment in Children On Mechanical Ventilation

👨‍⚕️ Chani Traube, MD, Weill Medical College of Cornell University📍 15 sites📅 Started Dec 2025View details ↗
Phase 2RecruitingNCT07104565

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders

👨‍⚕️ Incyte Medical Monitor, Incyte Corporation📍 40 sites📅 Started Dec 2025View details ↗
RecruitingNCT07226622

Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial

🏥 Prime Medicine, Inc.📍 7 sites📅 Started Dec 2025View details ↗
Phase 2Enrolling by InvitationNCT07209332

Open-Label Extension Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy

👨‍⚕️ Medical Director, MD, Wave Life Sciences📍 3 sites📅 Started Dec 2025View details ↗
NARecruitingNCT07233408

Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy

👨‍⚕️ Vanessa Merker, PhD, Massachusetts General Hospital📍 1 site📅 Started Dec 2025View details ↗
Phase 1, PHASE2RecruitingNCT07098364

ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma

👨‍⚕️ Alexandre V. Hirayama, MD, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Dec 2025View details ↗
NARecruitingNCT07226934

An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers

👨‍⚕️ Jessica Hahne, MA, MPH, Washington University School of Medicine📍 1 site📅 Started Dec 2025View details ↗
Phase 1, PHASE2RecruitingNCT07266116

Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients

🏥 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.📍 23 sites📅 Started Dec 2025View details ↗
← PreviousPage 30 of 505Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →